Investing.com - UnitedHealth (NYSE: UNH) reported second quarter EPS of $6.80, $0.13 better than the analyst estimate of $6.67. Revenue for the quarter came in at $98.9B versus the consensus estimate of $98.72B.UnitedHealth sees FY 2024 EPS of $27.50-$28.00 versus the analyst consensus of $27.59.  UnitedHealth's stock price closed at $515.40. It is up 4.51% in the last 3 months and up 6.47% in the last 12 months.UnitedHealth saw 2 positive EPS revisions and 18 negative EPS revisions in the last 90 days. See UnitedHealth's stock price’s past reactions to earnings here.According to InvestingPro, UnitedHealth's Financial Health score is "great performance". Check out UnitedHealth's recent earnings performance, and UnitedHealth's financials here.Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendarDon't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year... 
In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. 
With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. 
So if UNH is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.